The booming mushroom industry envisages economic merits, and massive unutilized waste production (~ 20 %) creates an opportunity for valorization. Chitosan, a bioactive polysaccharide, has drawn immense attention for its invaluable therapeutic potential. Thus, the present study was conducted to extract chitosan from mushroom waste (MCH) for its prebiotic potential. The structural characterization of MCH was carried out using NMR, FTIR, and XRD. The CP/MAS-13CNMR spectrum of MCH appeared at δ 57.67 (C2), 61.19 (C6), 75.39 (C3/C5), 83.53 (C4), 105.13 (C1), 23.69 (CH3), and 174.19 (C = O) ppm. The FTIR showed characteristic peaks at 3361 cm-1, 1582 cm-1, and 1262 cm-1 attributed to -NH stretching, amide II, and amide III bands of MCH. XRD interpretation of MCH exhibited a single strong reflection at 2θ = 20.19, which may correspond to the "form-II" polymorph. The extracted MCH (~ 47 kDa) exhibited varying degrees of deacetylation from 79 to 84 %. The prebiotic activity score of 0.73 to 0.82 was observed for MCH (1 %) when supplemented with probiotic strains (Lactobacillus casei, L. helveticus, L. plantarum, and L. rhamnosus). MCH enhanced the growth of Lactobacillus strains and SCFA's levels, particularly in L. rhamnosus. The MCH also inhibited the growth of pathogenic strains (MIC of 0.125 and 0.25 mg/mL against E. coli and S. aureus, respectively) and enhanced the adhesion efficiency of probiotics (3 to 8 % at 1 % MCH supplementation). L. rhamnosus efficiency was higher against pathogens in the presence of MCH, as indicated by anti-adhesion assays. These findings suggested that extracted polysaccharides from mushroom waste can be used as a prebiotic for ameliorating intestinal dysbiosis

Lactic acid bacteria, mushroom, prebiotic, сhitosan, short chain fatty acid, waste valorization

1H NMR data:
missing...

There is only one chemically distinct structure:

SVGMWSMILES3D molIonize

 

[*]O[C@@H]1[C@@H](CO)O[C@@H]([*])[C@H](N)[C@H]1O

161.157 g/mol (C₆H₁₁R₂NO₄, R = next and previous repeats, not counted in mol weight)

Conventional piezoelectric materials from piezoceramic and polymer are non-renewable and could be toxic in nature, which limit its application in biomedical application. Chitosan, which is a natural polysaccharide, has the potential to be used as piezoelectric biomaterial which may provide the solution for toxicity, non-biodegradability and non-biocompatibility issues of conventional piezoelectric materials. Chitosan may be produced sustainably through extraction from fungal cell walls. This study aims to characterize chitosan extracted from fungi Aspergillus oryzae for piezoelectric application. A. oryzae was cultivated on modified Sabouraud dextrose broth medium. Alkaline treatment was performed on fungal biomass using 1 M NaOH for extraction and deacetylation of chitosan at 100 °C for 1 hour. Fourier transform infrared spectroscopy results showed that the broad absorption band that corresponds to hydrogen bonded O-H stretching vibrations overlapped with N-H stretching band. X-ray diffraction analysis confirmed the semicrystalline nature of the chitosan sample. Piezoelectric properties can be attributed to intrinsic molecular polarization arising from the noncentrosymmetric crystal structure.

chitosan, Aspergillus oryzae, piezoelectric material

There is only one chemically distinct structure:

SVGMWSMILES3D molIonize

 

[*]O[C@@H]1[C@@H](CO)O[C@@H]([*])[C@H](NC(C)=O)[C@H]1O

203.194 g/mol (C₈H₁₃R₂NO₅, R = next and previous repeats, not counted in mol weight)

Two chitosan extracts were prepared by chemical and enzymatic treatment of Ganoderma lucidum mushroom, as an alternative source to crustacean shells. The molecular weight of the enzymatic extract was lower than that of the chemical one and of shrimp chitosan, as determined by viscosity measurements. Characteristic signals were identified in the 1 H-NMR spectra and high deacetylation degree indicated good physico-chemical properties for both mushroom chitosan extracts. The scavenging capacity of mushroom chitosan extracts was moderate against the synthetic radicals of 2,2'-azinobis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) and 1,1-diphenyl-2-picrylhydrazyl (DPPH), but higher values were observed for the enzymatic extract, compared to the chemical extract and shrimp chitosan. In vitro cytotoxicity was evaluated in L929 mouse fibroblast cell lines and the results of MTT assay showed good cytocompatibility in the tested range of concentrations. The growth of Gram-positive bacteria was inhibited more than Gram-negative bacteria in the presence of mushroom chitosan extracts, in particular by the chemical one, indicating their efficiency as antimicrobial agents. All these results strengthen the evidence of mushroom polysaccharide preparations availability for biomedical applications.

extraction, deacetylation, fungi, radical scavenging activity, α-amylase

There is only one chemically distinct structure:

SVGMWSMILES3D molIonize

 

*O[C@@H]1[C@@H](CO)O[C@@H](*)[C@H](NC(C)=O)[C@H]1O

203.194 g/mol (C₈H₁₃R₂NO₅, R = next and previous repeats, not counted in mol weight)

Two chitosan extracts were prepared by chemical and enzymatic treatment of Ganoderma lucidum mushroom, as an alternative source to crustacean shells. The molecular weight of the enzymatic extract was lower than that of the chemical one and of shrimp chitosan, as determined by viscosity measurements. Characteristic signals were identified in the 1 H-NMR spectra and high deacetylation degree indicated good physico-chemical properties for both mushroom chitosan extracts. The scavenging capacity of mushroom chitosan extracts was moderate against the synthetic radicals of 2,2'-azinobis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) and 1,1-diphenyl-2-picrylhydrazyl (DPPH), but higher values were observed for the enzymatic extract, compared to the chemical extract and shrimp chitosan. In vitro cytotoxicity was evaluated in L929 mouse fibroblast cell lines and the results of MTT assay showed good cytocompatibility in the tested range of concentrations. The growth of Gram-positive bacteria was inhibited more than Gram-negative bacteria in the presence of mushroom chitosan extracts, in particular by the chemical one, indicating their efficiency as antimicrobial agents. All these results strengthen the evidence of mushroom polysaccharide preparations availability for biomedical applications.

extraction, deacetylation, fungi, radical scavenging activity, α-amylase

13C NMR data:
missing...

There is only one chemically distinct structure:

SVGMWSMILES3D molIonize

 

[*]O[C@@H]1[C@@H](CO)O[C@@H]([*])[C@H](NC(C)=O)[C@H]1O

203.194 g/mol (C₈H₁₃R₂NO₅, R = next and previous repeats, not counted in mol weight)